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ABSTRACT
Neurological deterioration after acute ischemic stroke (AIS)is a common occurrence, leading to increased mortality,
morbidity, and poor quality of life among stroke survivors. Recognition of the individuals at a greater risk for neurological
deterioration may contribute to making early decisions and monitoring the therapy. Neurological deterioration arises in
up to 40% of subjects after AIS during hospitalization and is followed by neurological and functional debility. Numerous
predictors have been devised that predict this progression. This includes preliminary assessment of the severity of
stroke, brainstem infarction, hyperglycemia, atrial fibrillation, diabetes mellitus and substantial fluctuations in blood
pressure. Sequential observations, in depth analysis, and skilled professionals in specific stroke centers are crucial in
early recognition, prevention and management of neurological deterioration in AIS patients. Recent advancements in
the neurological and vascular imaging have contributed to providing a better understanding of the underlying
mechanisms, though several questions remain unanswered. There is an immense need to evaluate the risk of
neurological deterioration after AIS. This concise review summarizes the published data and highlights the causes,
mechanisms and the risk factors that influence the incidence of neurological deterioration in patients with AIS.
KEY WORDS: stroke; outcome; deterioration; mortality; AIS; ischemic stroke.
INTRODUCTION
Acute ischemic stroke (AIS) is one of the leading
causes of morbidity and mortality in adults.[1] AIS may
be followed by neurological deterioration (ND) during
the first 24-72 hours, also known as clinical worsening,
progressive stroke, or stroke in evolution. Although
various definitions of ND have been used across
different studies, a more practical definition of the ND
is an increase of 4 points in the National Institutes of
Health Stroke Scale (NIHSS) in major acute stroke or 2
points in NIHSS in minor stroke admitted within 24
hours of stroke onset.[2,3] The incidence of ND may rise
to 40% of AIS patients during hospitalization and is
associated with both short-term and long-term
neurologic and functional debility.[4] Multiple risk factors
have been investigated to predict this progression in
AIS patients, which comprise of preliminary
assessment of stroke severity, blood pressure changes,
brainstem infarction, hypoglycemia, hyperglycemia,
atrial fibrillation, cardiac arrest, and diabetes mellitus
(DM).[5,6] We categorized ND into early neurological
deterioration (END), which occurs within 24 hours of
AIS; and late neurological deterioration, which occurs
within 24-72 hours of AIS, although some authors have
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defined END up to 7 days.[7] It has been noted that
even a minor deterioration in NIHSS points has been
related to a worse prognosis when compared to those
patients who do not deteriorate.[6] There is limited data
available regarding the association between stroke
etiology and risk of ND, therefore, there is an immense
need to evaluate the risk of ND after AIS. This concise
review summarizes the published data from the
literature and highlights the risk factors that influence
the occurrence of ND in subjects with AIS.
METHODS
A detailed literature search was carried out using a
combination
of
different
keywords
including
“Neurological
deterioration,
early
neurological
deterioration, ND, END, acute stroke, acute ischemic
stroke, and AIS” in various databases like Cochrane
library, PubMed, Science direct, and web of science.
Inclusion criteria were (1) Adult subjects > 18 years
with AIS irrespective of vascular terrain or primary
mechanism; (2) reflected END as any point of
deterioration throughout 24 hours after hospital
admission; and (3) studies available in the English
language. The literature on ND following AIS and the
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delivered a pronounced understanding of their role in
END after AIS.[3-11,14]

risks factors associated with its progression were
critically reviewed. Randomized studies, retrospective
studies, cohort studies, case series, and case reports
were included in our study making it to a total of 20
articles that were searched and 10 were finalized for
input. While editorials, commentaries, letters to
editors, and abstract conferences remained in
exclusion criteria. The citations of selected articles and
reviews were also hand-searched.

CAUSES OF END
A limited number of studies have described the causes
of END. Overall, based on the studies included in this
review, only one has discussed the other causes of END
apart from symptomatic intracerebral hemorrhage
(sICH). Many factors have been reported so far that
cause END. Malignant edema has been reported as
one of the important causes of END. The prevalence of
14 % to 17 % was reported among all END patients
which demonstrating -2–3% of the overall AIS
sample.[8] Early recurrent ischemic stroke is reported
to be an uncommon cause of END, with a prevalence of
0.6% and 1.8% in patients of acute strokes in which
thrombolysis was done.[15] However, it is vital to
underline the significance of an early recurrent
ischemic stroke as a 100% mortality rate was reported
following ND these patients.[15] Early symptomatic
seizures have also been reported as the cause of END.
In a vast cohort study of AIS patients treated with
endovascular therapy, the prevalence of early seizures
( 24h) was 3.2%.[8]

INCIDENCE OF END
The actual incidence of END is difficult to assess because
of variable definitions of END used across different
studies.[3-11] Considering the eight studies in table 1 and
excluding overlapping studies, the incidence of END
varies broadly from 9.9% to 37.5%.[3-11] However, the rate
of prevalence of END was almost similar in the two
studies that used the definition ∆NIHSS ≥4 (18% and
18.9% and 20.6%).[8,12]
PREDICTORS OF END
Numerous papers have reported and proposed variable
factors that could predict END after AIS. The risk of END
increases with the severity of initial stroke.[13]
Hyperglycemia, Hypoglycemia, higher or lower NIHSS,
elevated blood pressure, history of diabetes, coronary
artery disease, use of aspirin, and longer admission
delays are some of the predictors reported in the
literature.[3-6] Certain other factors like age, sex, and
pre-stroke level of impartiality do not commonly seem
to be substantial risk aspects for END.[14] Some studies
reported age as one of the factors for the onset of
END.[5]

RISK FACTORS ASSOCIATED WITH END
Huang et al. [16] suggested that certain factors like
hyperglycemia, endovascular therapy (EVT), and
hyperuricemia may be independently associated with
END in AIS. Out of 213 patients attended after AIS, the
prevalence of END was found in 31.9% (n=68) of the
patients. Multivariate analysis revealed that END was
certainly related to the glucose level in the blood, uric
acid level, and treatment techniques. The most
significant finding outcome was that a higher risk of
END occurrence is closely associated with EVT when
compared with those patients who received intravenous
recombinant tissue-type plasminogen activator (rt-PA).
Heck and Brown reported a greater prevalence of
symptomatic transformation in patients treated with
EVT when compared with IV rt-PA.[17] Another study
reported an END incidence of 35.2% (44 out of 125) of
the AIS patients within seven days post-stroke who
underwent EVT. The majority of which (86.4%; n=38)
occurred with 72 hours.[7]

MECHANISMS OF END
Various mechanisms have been suggested to explain
END after AIS. They comprise of 1) recurrent stroke As
patients with AIS are at a higher risk of re-stroke in the
first week but recurrent strokes noticed on
diffusion-weighted MRI scans may not always produce
new and discrete clinical manifestations. 2) Failure of
collateralization; Occlusion of main cerebral vessels is
one of the utmost significant predictors of END that
leads to distal hypoperfusion unless actual circulation
recanalizes. The development of collateral vessels
helps in limiting the ischemic brain damage and further
ensures quick recovery after an AIS. Inadequate
collaterals with the resultant metabolic significances on
the ischemic penumbra were reported as the most
common mechanism of END. Other mechanisms of
END include elevated intracranial pressure, clot
progression,
cerebral
edema,
seizures,
and
intraparenchymal
hemorrhagic
transformation.
Advancements in cerebral vascular imaging have
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Helleberg et al. [8] reviewed numerous studies to
observe an association between END after AIS and the
functional level of these patients at 3 months
post-stroke. The authors concluded that END
measured by the change of at least 2 points in
Scandinavian Stroke Scale (SSS) and/or NIHSS
predicted poor short-term and long-term outcomes in
AIS patients and reported that SSS is not inferior to
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blood pressure, smoking, coronary artery disease, use
of antiplatelet agents, and admission delays are some
of the risk factors for END. In many patients, the cause
of END cannot be determined despite detailed
investigations, such cases are referred to as
unexplained End (UnEND).

NIHSS in measuring the END or predicting outcome in
these patients. Many reasons for clinical deterioration
were also reported, including vascular pathology,
weakened physiological homeostasis, local effects, and
biochemical disorders.[8]
Siegler et al. [6] conducted a study on 961 AIS patients
to look for END and its association with the stroke
etiology (as per the TOAST classification). 323 patients
(34%) experienced END. The large artery strokes,
particularly involving the internal carotid artery (ICA),
had an independent three-time higher risk of END (OR:
3.0; 95% CI, 1.4-6.6), whereas strokes of unidentified
etiology were least often associated with END (OR=
0.6; 95% CI 0.4-1.0).[6]

Girot et al. [20] studied the AIS patients with UnEND. A
total of 1925 AIS patients were included in the study,
out of which 128 (6.6%) experienced UnEND. They
noticed that AIS patients with non-modifiable aspects
are at greater risk to experience UnEND. The main
predictors of UnEND were reported to be pre-stroke
modified Rankin Scale ≥2 (OR, 2.22 [95% CI,
1.09–4.55]), initial NIHSS (OR, 0.65 [95% CI,
0.52–0.81]), general anesthesia (OR, 2.55 [95% CI,
1.51–4.30]), diabetes mellitus (OR, 2.17 [95% CI,
1.32–3.56]), and elevated blood pressure (OR, 1.10
[95% CI, 1.01–1.20]).[20]

Another study reviewed the association of different
causes of stroke, reversible and non-reversible, with
the time of onset of END.[5] They had a cohort of 350
patients with AIS, 71 (20.28%) of which experienced
ND and approximately half of these patients
experienced END within 48 hours of a stroke. The
patients with increased severity of the stroke
experienced END early as compared to the patients
with milder stroke. A one-point increase in the NIHSS
score on admission resulted in a 3.1% shorter time to
END (p=0.0034). The authors also noted that age has
an inverse relation to the median onset of END, even
after adjusting for different confounders, including
NIHSS score on admission. For each one-year increase
in patient’s age, a shorter time of 3.9% to ND
(p=0.0257) was reported.[5]

Advances in specialized stroke care units greatly
improve stroke care. The stroke care units categorize
the stroke patients based on their stroke severity and
take active measures in high-risk patients to prevent
and manage END appropriately. Rapid initiation of
antithrombotic therapy and EVT results in improves
morbidity. Proper monitoring of hypotension, large
vessel obstruction, atrial fibrillation, hyperglycemia, and
high body temperature is crucially important to prevent
initial neurological deterioration and to improve the
patient outcome.
FUTURE DIRECTIONS
END is more common than previously thought in AIS
patients. To establish the exact incidence and
prevalence of END, the global stroke community should
uniformly decide and implement a widely acceptable
definition of END. This will help in promoting the END
research and in comparison, of the different studies to
evaluate the risk factors of END and the crucial steps to
prevent and manage it. Since stroke is one of the
leading causes of morbidity and mortality in adults, the
knowledge, prevention, and management of END along
with the establishment of ubiquitous stroke care units
will significantly improve the stroke outcome.
`

Malignant edema is reported as one of the causes of
END and its incidence among all END24 patients
ranged from 14% to 27%. Given its interval
progression, malignant edema is expected to occur in
later stages of END.[8] This statement would be
supported by the reported prevalence of 6.5 % fatal
swelling of brain in a large group of patients admitted to
the hospital with circulation strokes.[18]Various
mechanisms of END include elevated intracranial
pressure, clot progression, cerebral edema, seizures,
and hemorrhagic transformation.[14]
Deranged blood sugar levels, both hyperglycemia, and
hypoglycemia, are associated with END. Moreover,
hyperglycemia on admission is related to sICH after EVT
in AIS with resultant poor outcomes. In experimental
models, it was proposed that an acute hyperglycemia
leads to an increase in cerebral lactate production,
followed by brain edema, which may contribute to the
early development of END.[19] Apart from deranged
blood sugar levels, other factors, for instance, elevated
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